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論文概要 
Dissertation Abstract 
Abstract 
1. Purpose 
Mouse embryonic stem cells (mESCs) and epiblast stem cells (mEpiSCs) are derived from pre- and 
post-implantation epiblast, respectively. These two pluripotent stem cell (PSC) types represent the naïve 
and primed pluripotent states which exhibit significant differences in cell morphology, gene expression 
pattern, epigenetic status and chimera formation. PSCs harbor the capacity to self-renew indefinitely in 
vitro and to differentiate into all cell types of an adult organism, which holds a significant promise for 
disease modeling, drug screening, and cell-replacement therapies as well as makes them ideal models to 
study early embryonic development in mammals. It has been accepted that heterogeneity is one of the 
underlying mechanisms which allows PSCs to maintain their unlimitedly self-renewal capacity while 
remaining capable of responding to inductive differentiation signals. However, how heterogeneity evolves 
as a molecular basis for PSC self-renewal and differentiation remains an open question. The main purposes 
of this thesis are: 
- To examine the underlying mechanisms of how the heterogeneity of mESCs is regulated. To 
this end, we focus on Rex1 expression, a well-known pluripotency gene specifically expressed 
in mESCs in a heterogeneous pattern. 
- To investigate whether mEpiSCs contain distinct subpopulations that vary in differentiation 
potential. We employ Fgf5 expression as a model to gain novel insights in this regard. 
2. Materials and methods 
To investigate metabolic regulation of mESC heterogeneity, we took advantage of a double knock-
in cell line, OCRG9 ES cells, where genes for CFP and GFP were inserted into Oct3/4 and Rex1 genes, 
respectively, to trace their expression patterns. We first examined global gene expression of facs-sorted 
Rex1-positive and Rex1-negative cells by microarray analysis. Considering that we found significant 
Title of Doctor Dissertation: Regulation of Transcriptional Heterogeneity in Pluripotent Stem Cells 
                               (多能性幹細胞における転写不均一性の制御) 
 
Last or Family Name First Middle 
Le  Khoa  Tran Phuc  
Student Number 
201230517  
Primary Academic Advisors 
Affiliation: Faculty of Medicine, Division of Biomedical Science   
Name: Satoru Takahashi   
HBP form 4 
  School of Integrative and Global Majors 
Ph.D. Program in Human Biology (HBP)
  
differences in the expression levels of glycolysis- and antioxidant-related genes, we then focused on the 
potential functions of glycolysis and ROS in the dynamic and mutual conversion of Rex1-positive and 
Rex1-negative cells. To this end, we used various pharmacological and genetic approaches to explore the 
effects of glycolysis pathway and ROS signaling on the regulation of mESC heterogeneity. 
To examine the heterogeneity in mEpiSCs, we focused on Fgf5 gene expression which has not been 
studied with regard to heterogeneous expression. First, we generated Fgf5-P2A-Venus Bacterial Artificial 
Chromosome (BAC) transgenic (Tg) mice, and showed that the BAC Tg can recapitulate endogenous 
Fgf5 expression in the epiblast and visceral endodermal cells of E6.5 and E7.5 embryos. We then 
established Tg mEpiSCs in vitro from E6.5 Tg embryos and explored heterogeneous expression of Fgf5 
based on Venus expression. To determine whether there are distinct differentiation biases of 
subpopulations in Tg mEpiSCs, we compared gene expression patterns in each subpopulation of Tg 
mEpiSCs, and found significant differences in expression levels of lineage-specific genes. 
3. Result 
3.1. Metabolic regulation of mouse ESC heterogeneity 
3.1.1. Significant differences in glycolytic metabolism in mESC subpopulations 
Microarray analysis in facs-sorted Rex1-positive and Rex1-negative cells showed that highly 
expressing genes associated with glycolysis pathway, such as Glut1, Gapdh, Pgk1, Eno3, and Ldha, were 
preferentially detected in Rex1-negative cells as compared to Rex1-positive cells. These microarray data 
were validated by RT-qPCR analysis in facs-sorted Rex1-positive and Rex1-negative cells, suggesting that 
Rex1-negative population may possess an increased level of glycolysis relative to Rex1-positive 
population. Indeed, lactate production rate, which is considered as a critical indicative of glycolysis, was 
lower in Rex1-positive cells than Rex1-negative cells. Given that glycolysis has recently been appreciated 
to play crucial roles in the maintenance and establishment of ESC pluripotency, we decided to explore the 
potential roles of glycolysis in the regulation of mESC heterogeneity which have not been investigated. 
This work will be published within three years. 
3.1.2. Pharmacological and genetic suppression of glycolysis impairs mESC heterogeneity 
 To explore the effect of differences in glycolytic metabolism on the ratio of Rex1-positive and 
Rex1-negative cells in OCRG9 ES cells, we exposed OCRG9 ESCs to 2-Deoxy-D-Glucose (2-DG) or 2-
Fluoro-Deoxy-D-Glucose (2-FDG), two independent well-known glycolysis inhibitors. Interestingly, 2-
DG or 2-FDG treatment resulted in a decrease in Rex1-negative population while an increase in Rex1-
positive population was observed. These data support the hypothesis that glycolytic metabolism is 
involved in the behavior of subpopulations in mES cell culture, and that suppression of glycolysis pathway 
compromises mESC heterogeneity. In addition, glycolysis suppression by 2-DG or 2-FDG dynamically 
affected the temporal interchange and speed of interconversion of facs-sorted Rex1-positive and Rex1-
negative cells, resulting in enrichment of Rex1-positive cells during the mutual interconversion.  
To genetically recapitulate the effect of glycolysis on mESC heterogeneity observed in our 
pharmacological experiments, we knock-downed Hexokinase-2 (Hk2) expression, a gene encoding for the 
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first rate-limiting glycolysis enzyme Hk2, by using the third-generation Tet-responsive promoter (TRE3G) 
and the third-generation Tet activator (TET3G) coupled with RNA interference (RNAi). We found that 
inhibition of Hk2 caused a dramatic reduction of Rex1-negative cells with a concomitant increase in Rex1-
positive cells. These data strongly indicated that similar to the results observed in 2-DG or 2-FDG 
treatment, Hk2 knockdown-mediated suppression of glycolysis impaired the metastable state of mESCs, 
reinforcing our observation in that glycolysis pathway is indeed an intrinsic factor regulating mESC 
heterogeneity. This work will be published within three years. 
3.1.3. 2-DG-induced generation of ROS is required for the transition from Rex1-negative to 
Rex1-positive cells 
We next attempted to unravel the connection between glycolysis inhibition and the enrichment of 
Rex1-positive fraction by ascertaining the downstream effectors of 2-DG-mediated glycolysis 
downregulation. We found that there was an induction in cytoplasmic (cyto) ROS levels in 2-DG-treated 
OCRG9 ES cells, which could be completely rescued by co-treatment with antioxidant N-acetylcysteine 
(NAC). Notably, NAC incubation significantly dampened 2-DG-mediated enrichment of Rex1-positive 
cells from Rex1-negative cells. Taken together, our results demonstrate that ROS generation downstream 
of glycolysis inhibition is an essential factor controlling the process of Rex1-negative to Rex1-positive cell 
conversion. This work will be published within three years. 
3.2. Investigation of mEpiSC heterogeneity 
3.2.1. Fgf5-P2A-Venus BAC Tg mice can mirror Fgf5 expression during the early embryonic 
development 
To generate transgenic (Tg) mice recapitulating endogenous Fgf5 expression, a BAC clone was 
used to cover the entire genomic region of Fgf5 with a modification at the third exon in which the P2A 
(porcine teschovirus-1 self-cleaving peptide)-Venus reporter cassette was inserted into the third exon of 
Fgf5. We generated six lines of Fgf5-P2A-Venus BAC Tg mice. To check Venus expression, we dissected 
embryos at E6.5 and 7.5 from 6 Tg lines, and found strong Venus expression in the epiblast and visceral 
endodermal cells of E6.5 and E7.5 Tg embryos, indicating that Fgf5-P2A-Venus BAC Tg construct can 
recapitulate endogenous Fgf5 expression. This work has been published in PLoS One. 2016;11: 
e0159246. doi:10.1371/journal.pone.0159246. 
3.2.2. Fgf5 heterogeneous expression in Tg mEpiSCs 
To confirm the Fgf5-P2A-Venus BAC Tg expression in vitro, we established mEpiSCs by culturing 
the epiblast of E6.5 Fgf5-P2A-Venus BAC Tg embryos in NDiff227 medium supplemented with bFGF 
and Activin. Our established Tg mEpiSCs harbor defining features of bona fide mEpiSCs with regard to 
cell morphology and gene expression pattern. Flow cytometric analysis showed that most Tg mEpiSCs, if 
not all, expressed Venus, consistent with uniform Venus expression in the epiblast of the E6.5 Tg embryo. 
We also confirmed that upon reprogramming into naïve state, Venus was suppressed in resulting mES-like 
cells.  
Furthermore, while most Tg mEpiSCs expressed Venus abundantly, surprisingly the Tg mEpiSCs 
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contained a minor subpopulation of Venus-negative cells that were capable of conversion to Venus-
positive cells, indicating that Fgf5 expression shows dynamic heterogeneity in mEpiSCs. In addition, gene 
expression analysis revealed that, while Fgf5-positive cells predominantly expressed important 
mesendodermal markers such as T, Sox17 and Foxa2, Fgf5-negative cells exhibited a high expression 
level of the ectodermal marker Sox1. These results suggest the possibility that the heterogeneous 
expression of Fgf5 observed in our study may be the foundation for the distinct differentiation biases of 
subpopulations in mEpiSCs. This work has been published in PLoS One. 2016;11: e0159246. 
doi:10.1371/journal.pone.0159246. 
4. Discussion 
4.1.Novel function of glycolysis/ROS axis in regulation of mESC heterogeneity 
Our results showed that Rex1-negative cells possessed an increased level of glycolysis pathway 
relative to Rex1-postive cells at gene expression levels and enzymatic activity. Pharmacological or genetic 
inhibition of glycolysis pathway impaired mESC heterogeneity, resulting in a significant enrichment of 
Rex1-positive cells without causing cell death. Whether glycolysis pathway maintains mESC 
heterogeneity through regulation of histone acetylation and how glycolysis pathway executes its role in 
differentiation propensity of Rex1-positive and Rex1-negative cells would be interesting topics for future 
investigation.  
Interestingly, we found that glycolysis inhibition caused an increase in the levels of reactive oxygen 
species (ROS) whose suppression by the antioxidant abolished the Rex1-negative cell-derived enrichment 
of Rex1-positive cells induced by glycolysis inhibition. Our data, thus, highlight a novel function of 
glycolysis/ROS axis in the regulation of dynamic equilibrium of mESC subpopulations. Investigation of 
whether glycolysis inhibition causes significant changes in downstream signaling cascades, such as 
MEK/ERK, BMP4, WNT or TGFβ, will provide more insights in this regard.  
This work will be published within three years. 
4.2. Heterogeneity in Fgf5-P2A-Venus BAC Tg mEpiSCs  
In this study, we generate Fgf5-P2A-Venus BAC Tg mice and demonstrate that the BAC transgene 
can recapitulate endogenous Fgf5 expression in the postimplantation epiblast and visceral endoderm of 
Tg embryos. To the best of our knowledge, this is the first Tg mouse model allowing for the visualization 
of endogenous Fgf5 expression during early embryonic development. Future work will delineate the actual 
cell fates of Fgf5-positive epiblast cells during gastrulation, which would provide important insights into 
how the ectoderm lineage is established and regulated in the gastrulating mouse embryo. 
Our data also show that Fgf5-Venus overall uniformly marks mEpiSCs. However, surprisingly, 
there is a small subpopulation of Fgf5-Venus-negative cells in mEpiSCs that are capable of conversion to 
Fgf5-Venus-positive cells, indicating that Fgf5 expression shows dynamic heterogeneity in mEpiSCs (Fig 
1). Our gene expression analysis revealed that, while Fgf5-Venus-positive cells predominantly expressed 
important mesendodermal markers such as T, Sox17 and Foxa2, Fgf5-negative cells exhibited a high 
expression level of the ectodermal marker Sox1. Thus, Investigation of the differentiation propensity of 
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Fgf5-Venus-positive and -negative mEpiSCs in response to differentiation stimuli, such as BMP signaling, 
will be of a great interest in future studies (Fig 1). This work has been published in PLoS One. 2016;11: 
e0159246. doi:10.1371/journal.pone.0159246. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Fgf5-P2A-Venus BAC transgene can mirror endogenous Fgf5 expression both in 
vivo and in vitro. Venus expression was seen in the postimplantation epiblast and visceral endoderm of 
Tg embryos. Tg mEpiSCs established from E6.5 Tg embryos contain two subpopulations in terms of Fgf5 
expression. Interestingly, Fgf5-postive and Fgf5-negative Tg mEpiSCs are interconvertible, and exhibit 
differentiation potential towards mesendoderm and ectoderm lineages, respectively. The responses of 
these two subpopulations to WNT and BMP4 signaling during the mutual conversion and lineage 
specification are of great interest in future work.  
 
